To date, a number of clinical trials have shown weight regain after discontinuing GLP-1 drugs. In the STEP 1 trial extension, ...

Results of the human clinical trial will be shared with LifeVantage Consultants at Market Connect in Kansas City, October ...

With 890 million people affected globally and 42% of American adults classified as obese, the allure of a "miracle" weight ...

Vivani Medical today announced that Australian authorities approved a first-in-human clinical trial for its subdermal GLP-1 ...

Biocon said that it has signed a licensing and supply agreement with Tabuk Pharmaceutical Manufacturing Company to commercialize its GLP-1 products for treating diabetes and chronic weight management, ...

In 1970, with a degree from the medical school of the University of Copenhagen (UCPH), Professor Jens Juul Holst embarked on ...

Semaglutide (Ozempic, Wegovy) may help reduce the risk of an opioid overdose in certain people, an emulation target trial suggested.

According to health experts, if you eat the right foods, your body will trigger the natural release of GLP-1, which is what ...

Bengaluru: Biocon Limited, a global biopharmaceutical company, has announced the signing of a licensing and supply agreement ...

This partnership aligns with both companies' strategies to address the growing demand for effective diabetes treatments in ...

The effectiveness can vary based on the individual response and adherence to treatment. Research indicates that GLP-1 ...

LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular ...